資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/30960
|
| 標題: | Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca2+ sensitization |
| 作者: | Liu, Chung-Pin
Yeh, Jwu-Lai
Liou, Shu-Fen
Wu, Bin-Nan
Chen, Ing-Jun |
| 貢獻者: | Yuans Gen Hosp, Dept Internal Med
Kaohsiung Med Univ, Sch Med, Dept Pharmacol
Chia Nan Univ Pharm & Sci, Dept Pharm
Pingtung Christian Hosp, Dept Med & Educ |
| 關鍵字: | Ca2+ entry
Cardiac output
Cardioprotection
PKG
G-protein-coupled receptor
cgmp |
| 日期: | 2016-02 |
| 上傳時間: | 2018-01-18 11:38:45 (UTC+8) |
| 出版者: | Elsevier Taiwan |
| 摘要: | KMUP-3 (7-{2-[4-(4-nitrobenzene) piperazinyl]ethyl}-1, 3-dimethylxanthine) displays cardioprotection and increases cardiac output, and is suggested to increase cardiac performance and improve myocardial infarction. To determine whether KMUP-3 improves outcomes in hypoperfused myocardium by inducing Ca2+ sensitization to oppose protein kinase (PK) G-mediated Ca2+ blockade, we measured left ventricular systolic blood pressure, maximal rates of pressure development, mean arterial pressure and heart rate in rats, and measured contractility and expression of PKs/RhoA/Rho kinase (ROCK) II in beating guinea pig left atria. Hemodynamic changes induced by KMUP-3 (0.5-3.0 mg/kg, intravenously) were inhibited by Y27632 [(R)-(+)-trans-4-1-aminoethyl)-N-(4-Pyridyl) cyclohexane carboxamide] and ketanserin (1 mg/kg, intravenously). In electrically stimulated left guinea pig atria, positive inotropy induced by KMUP-3 (0.1-100 mu M) was inhibited by the endothelial NO synthase (eNOS) inhibitors N-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole, cyclic AMP antagonist SQ22536 [9-(terahydro-2-furanyl)-9H-purin-6-amine], soluble guanylyl cyclase (sGC) antagonist ODQ (1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one), RhoA inhibitor C3 exoenzyme, beta-blocker propranolol, 5-hydroxytryptamine 2A antagonist ketanserin, ROCK inhibitor Y27632 and KMUP1 (7-{2-[4-(2-chlorobenzene) piperazinyl]ethyl}-1, 3-dimethylxanthine) at 10 mu M. Western blotting assays indicated that KMUP-3 (0.1-10 mu M) increased PKA, RhoA/ROCKII, and PKC translocation and CIP-17 (an endogenous 17-kDa inhibitory protein) activation. In spontaneous right atria, KMUP-3 induced negative chronotropy that was blunted by 7-nitroindazole and atropine. In neonatal myocytes, L-NAME inhibited KMUP-3-induced eNOS phosphorylation and RhoA/ROCK activation. In H9c2 cells, Y-27632 (50 mu M) and PKG antagonist KT5823 [2,3,9,10,11,12-hexahydro-10R- methoxy-2,9-dimethyl-1-oxo-9S, 12R-epoxy-1H-diindolo(1,2,3-fg: 3',2',1'-kl) pyrrolo(3,4-i)(1,6)benzodiazocine-10-carboxylic acid, methyl ester] (3 mu M) reversed KMUP-3 (1-100 mu M)-induced Ca2+-entry blockade. GPCR agonist activity of KMUP-3 appeared opposed to KMUP-1, and increased cardiac output via Ca2+ sensitization, and displayed cardioprotection via cyclic GMP/PKG-mediated myocardial preconditioning in animal studies. Copyright (C) 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. |
| 關聯: | Kaohsiung Journal of Medical Sciences, v.32 n.2, pp.55-67 |
| 顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 30960.pdf | | 2081Kb | Adobe PDF | 307 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1162 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
